Items tagged with Diagnostics
Activists call for withdrawal of substandard TB test from India (post with simple image)
TB activists urge the Drug Controller General of India to withdraw GeneDrive test for TB from the Indian market.
2016 i-Base/TAG Pipeline Report (post with simple image)
Latest annual review on HIV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure, and immune-based and gene therapies in development.
A diagnostics breakthrough (post with simple image)
Product design and development firm Cambridge Consultants is working with medical device start-up WaveGuide Corporation on a world first to tackle the global problem of tuberculosis (TB), as well as other diseases. The two companies are developing a unique portable nuclear magnetic resonance (NMR) scanner to provide fast, low-cost, point-of-care (POC) testing for disease in developing countries and geographically remote locations.
WHO recommends new TB test (post with simple image)
Robust, rapid DNA-based test can serve as an alternative to sputum smear microscopy.
Advocates encourage the establishment of an essential diagnostics list (post with simple image)
A resource to efficiently and proactively communicate to country governments the diagnostic tests that are worthy and indeed essential for approval and use is needed.
Advocates encourage Danaher to continue investments in Cepheid’s TB products (post with simple image)
TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.
An Activist’s Guide to Tuberculosis Diagnostic Tools (post with simple image)
The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.
Advocates call on PEPFAR to roll out LAM test (post with simple image)
TB advocates urge PEPFAR to provide immediate access to the LAM test for TB diagnosis in HIV-positive people with advanced immunosuppression.
Next-generation Xpert® MTB/RIF Ultra assay recommended by WHO (post with simple image)
The World Health Organization (WHO) recommends the use of a next-generation Xpert® MTB/RIF assay (called Xpert® MTB/RIF Ultra) as a replacement for the current Xpert MTB/RIF® cartridge.
WHO to develop Essential Diagnostics List (post with simple image)
Like the established Essential Medicines List, the Essential Diagnostics List is intended to provide evidence-based guidance to countries to create their own national lists of essential diagnostic tests and tools.
Page 44 of 47 · Total posts: 0←First 43 44 45 Last→